Open access

Showing results 31 - 40 of 100

Sorted by most recent

Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept study
Jagtar Singh Nijjar, Katharine Abbott-Banner, Yolanda Alvarez, Nicola Aston, Damon Bass, Jane H Bentley, Joanne Ellis, Christian Ellson, Edward C Emery, Maria Feeney, Disala Fernando, David Inman, Rejbinder Kaur, Louise K Modis, Sam Munoz VicenteSee the full list of authors

17 October 2024

Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial
Rosaria Talarico, Nazzareno Italiano, Giacomo Emmi, Matteo Piga, Luca Cantarini, Irene Mattioli, Alberto Floris, Stefano Gentileschi, Federica Di Cianni, Maria Letizia Urban, Emanuele Chiara, Diana Marinello, Alessandra Del Bianco, Michele Figus, Chiara PosarelliSee the full list of authors

17 October 2024

EULAR recommendations for the treatment of systemic sclerosis: 2023 update
Francesco Del Galdo, Alain Lescoat, Philip G Conaghan, Eugenia Bertoldo, Jelena Čolić, Tânia Santiago, Yossra A Suliman, Marco Matucci-Cerinic, Armando Gabrielli, Oliver Distler, Anna-Maria Hoffmann-Vold, Ivan Castellví, Alexandra Balbir-Gurman, Madelon Vonk, Lidia AnanyevaSee the full list of authors

11 October 2024

Prev12345678910Next